Cardio Diagnostics Holdings Inc. Warrant (CDIOW)

• Market cap: $675K
• 1 day: -14.04%
• 5 days: -35.81%
• 1 month: -57.39%
• 3 months: -79.00%
• 6 months: -46.55%
• Year to date: -82.50%
• 1 year: -75.54%
• 5 years: -95.55%
• 10 years: -95.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Employees: 9

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

17% more funds holding

Funds holding: 6 [Q4 2024] → 7 (+1) [Q1 2025]

0% more ownership

Funds ownership: 1.85% [Q4 2024] → 1.85% (+0%) [Q1 2025]

59% less capital invested

Capital invested by funds: $96.7K [Q4 2024] → $39.6K (-$57.1K) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1